These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 37175726)
21. Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites. Ding Y; Yanagi K; Cheng C; Alaniz RC; Lee K; Jayaraman A Pharmacol Res; 2019 Mar; 141():521-529. PubMed ID: 30660825 [TBL] [Abstract][Full Text] [Related]
22. Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway. Wei J; Zheng Z; Hou X; Jia F; Yuan Y; Yuan F; He F; Hu L; Zhao L J Ethnopharmacol; 2024 Jan; 318(Pt A):116866. PubMed ID: 37429503 [TBL] [Abstract][Full Text] [Related]
23. Gut microbiome-metabolites axis: A friend or foe to colorectal cancer progression. Wu H; Ma W; Wang Y; Wang Y; Sun X; Zheng Q Biomed Pharmacother; 2024 Apr; 173():116410. PubMed ID: 38460373 [TBL] [Abstract][Full Text] [Related]
24. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis. Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J mBio; 2020 Feb; 11(1):. PubMed ID: 32071266 [TBL] [Abstract][Full Text] [Related]
25. Microbial Metabolites Determine Host Health and the Status of Some Diseases. Sittipo P; Shim JW; Lee YK Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062 [TBL] [Abstract][Full Text] [Related]
26. Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases. Stec A; Sikora M; Maciejewska M; Paralusz-Stec K; Michalska M; Sikorska E; Rudnicka L Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834904 [TBL] [Abstract][Full Text] [Related]
27. Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis. Fettig NM; Osborne LC Microbes Infect; 2021; 23(6-7):104814. PubMed ID: 33775860 [TBL] [Abstract][Full Text] [Related]
28. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer. Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866 [TBL] [Abstract][Full Text] [Related]
29. Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer. Gou H; Zeng R; Lau HCH; Yu J Pharmacol Res; 2024 Oct; 208():107373. PubMed ID: 39197712 [TBL] [Abstract][Full Text] [Related]
30. "Driver-passenger" bacteria and their metabolites in the pathogenesis of colorectal cancer. Avril M; DePaolo RW Gut Microbes; 2021; 13(1):1941710. PubMed ID: 34225577 [TBL] [Abstract][Full Text] [Related]
31. PRM1201 effectively inhibits colorectal cancer metastasis via shaping gut microbiota and short- chain fatty acids. Jia R; Shao S; Zhang P; Yuan Y; Rong W; An Z; Lv S; Feng Y; Liu N; Feng Q; Wang Y; Li Q Phytomedicine; 2024 Sep; 132():155795. PubMed ID: 38878524 [TBL] [Abstract][Full Text] [Related]
32. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota. Ohtani N; Hara E Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882 [TBL] [Abstract][Full Text] [Related]
33. Molecular interactions between the intestinal microbiota and the host. Hertli S; Zimmermann P Mol Microbiol; 2022 Jun; 117(6):1297-1307. PubMed ID: 35403275 [TBL] [Abstract][Full Text] [Related]
34. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer. Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983 [TBL] [Abstract][Full Text] [Related]
35. Fiber, Fat, and Colorectal Cancer: New Insight into Modifiable Dietary Risk Factors. Ocvirk S; Wilson AS; Appolonia CN; Thomas TK; O'Keefe SJD Curr Gastroenterol Rep; 2019 Dec; 21(11):62. PubMed ID: 31792624 [TBL] [Abstract][Full Text] [Related]
36. Assessment of gut microbiota fecal metabolites by chromatographic targeted approaches. Fiori J; Turroni S; Candela M; Gotti R J Pharm Biomed Anal; 2020 Jan; 177():112867. PubMed ID: 31614303 [TBL] [Abstract][Full Text] [Related]
37. Gut microbiota derived short-chain fatty acids in physiology and pathology: An update. Archana ; Gupta AK; Noumani A; Panday DK; Zaidi F; Sahu GK; Joshi G; Yadav M; Borah SJ; Susmitha V; Mohan A; Kumar A; Solanki PR Cell Biochem Funct; 2024 Sep; 42(7):e4108. PubMed ID: 39228159 [TBL] [Abstract][Full Text] [Related]
38. Microbial metabolites in colorectal tumorigenesis and cancer therapy. Liu Y; Lau HC; Yu J Gut Microbes; 2023; 15(1):2203968. PubMed ID: 37095682 [TBL] [Abstract][Full Text] [Related]
39. Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms. Liu S; He Y; Zhang Y; Zhang Z; Huang K; Deng L; Liao B; Zhong Y; Feng J Gut Microbes; 2023 Dec; 15(2):2290331. PubMed ID: 38073096 [TBL] [Abstract][Full Text] [Related]
40. A prospective cohort analysis of gut microbial co-metabolism in Alaska Native and rural African people at high and low risk of colorectal cancer. Ocvirk S; Wilson AS; Posma JM; Li JV; Koller KR; Day GM; Flanagan CA; Otto JE; Sacco PE; Sacco FD; Sapp FR; Wilson AS; Newton K; Brouard F; DeLany JP; Behnning M; Appolonia CN; Soni D; Bhatti F; Methé B; Fitch A; Morris A; Gaskins HR; Kinross J; Nicholson JK; Thomas TK; O'Keefe SJD Am J Clin Nutr; 2020 Feb; 111(2):406-419. PubMed ID: 31851298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]